+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 1fyh | ||||||
---|---|---|---|---|---|---|---|
タイトル | 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR | ||||||
要素 |
| ||||||
キーワード | IMMUNE SYSTEM / CYTOKINE-RECEPTOR COMPLEX / FIBRONECTIN TYPE-III | ||||||
機能・相同性 | 機能・相同性情報 type II interferon receptor activity / positive regulation of fructose 1,6-bisphosphate metabolic process / positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity / positive regulation of tumor necrosis factor (ligand) superfamily member 11 production / positive regulation of iron ion import across plasma membrane / type II interferon receptor binding / positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response / negative regulation of tau-protein kinase activity / positive regulation of NMDA glutamate receptor activity / : ...type II interferon receptor activity / positive regulation of fructose 1,6-bisphosphate metabolic process / positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity / positive regulation of tumor necrosis factor (ligand) superfamily member 11 production / positive regulation of iron ion import across plasma membrane / type II interferon receptor binding / positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response / negative regulation of tau-protein kinase activity / positive regulation of NMDA glutamate receptor activity / : / positive regulation of vitamin D biosynthetic process / positive regulation of cellular respiration / positive regulation of peptidyl-serine phosphorylation of STAT protein / positive regulation of interleukin-23 production / negative regulation of amyloid-beta clearance / positive regulation of calcidiol 1-monooxygenase activity / positive regulation of protein deacetylation / type III interferon-mediated signaling pathway / RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) / positive regulation of smooth muscle cell apoptotic process / positive regulation of core promoter binding / neuroinflammatory response / positive regulation of exosomal secretion / positive regulation of killing of cells of another organism / macrophage activation involved in immune response / positive regulation of osteoclast differentiation / positive regulation of MHC class II biosynthetic process / negative regulation of interleukin-17 production / positive regulation of signaling receptor activity / positive regulation of membrane protein ectodomain proteolysis / positive regulation of neurogenesis / cytokine receptor activity / negative regulation of epithelial cell differentiation / positive regulation of amyloid-beta formation / IFNG signaling activates MAPKs / positive regulation of epithelial cell migration / cytokine binding / positive regulation of nitric-oxide synthase biosynthetic process / cell surface receptor signaling pathway via JAK-STAT / regulation of insulin secretion / humoral immune response / macrophage differentiation / positive regulation of autophagy / Regulation of IFNG signaling / type II interferon-mediated signaling pathway / extrinsic apoptotic signaling pathway / positive regulation of chemokine production / positive regulation of phagocytosis / positive regulation of tyrosine phosphorylation of STAT protein / positive regulation of interleukin-12 production / positive regulation of glycolytic process / Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation / positive regulation of interleukin-1 beta production / positive regulation of cytokine production / cytokine activity / astrocyte activation / positive regulation of protein localization to plasma membrane / negative regulation of smooth muscle cell proliferation / microglial cell activation / positive regulation of protein-containing complex assembly / response to virus / positive regulation of protein serine/threonine kinase activity / cellular response to virus / cytokine-mediated signaling pathway / positive regulation of protein import into nucleus / positive regulation of inflammatory response / positive regulation of interleukin-6 production / positive regulation of tumor necrosis factor production / Interferon gamma signaling / positive regulation of nitric oxide biosynthetic process / defense response to virus / adaptive immune response / Potential therapeutics for SARS / cell surface receptor signaling pathway / negative regulation of gene expression / negative regulation of DNA-templated transcription / apoptotic process / positive regulation of cell population proliferation / positive regulation of gene expression / negative regulation of transcription by RNA polymerase II / signal transduction / extracellular space / extracellular region / membrane / plasma membrane 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 解像度: 2.04 Å | ||||||
データ登録者 | Randal, M. / Kossiakoff, A.A. | ||||||
引用 | ジャーナル: Structure / 年: 2001 タイトル: The structure and activity of a monomeric interferon-gamma:alpha-chain receptor signaling complex. 著者: Randal, M. / Kossiakoff, A.A. #1: ジャーナル: Protein Sci. / 年: 1998 タイトル: Crystallization and Preliminary X-ray Analysis of a 1:1 Complex between a designed monomeric interferon-gamma and it soluble receptor 著者: Randal, M. / Kossiakoff, A.A. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 1fyh.cif.gz | 195.8 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb1fyh.ent.gz | 162.4 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 1fyh.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 1fyh_validation.pdf.gz | 390.9 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 1fyh_full_validation.pdf.gz | 400.7 KB | 表示 | |
XML形式データ | 1fyh_validation.xml.gz | 17.8 KB | 表示 | |
CIF形式データ | 1fyh_validation.cif.gz | 30.9 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/fy/1fyh ftp://data.pdbj.org/pub/pdb/validation_reports/fy/1fyh | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
2 |
| ||||||||
単位格子 |
| ||||||||
詳細 | the biological assembly consists of one single-chain interferon gamma and one receptor |
-要素
#1: タンパク質 | 分子量: 30146.277 Da / 分子数: 2 / 断片: UNP residues 24-143, 28-156 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: IFNG / プラスミド: PRSET / 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: P01579 #2: タンパク質 | 分子量: 25900.158 Da / 分子数: 2 / 断片: EXTRACELLULAR DOMAIN (UNP residues 18-246) / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: IFNGR1 / プラスミド: PAP / 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: P15260 #3: 化合物 | ChemComp-CL / | #4: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 2 |
---|
-試料調製
結晶 | マシュー密度: 2.95 Å3/Da / 溶媒含有率: 58.29 % | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 8.5 詳細: ammonium sulphate, PEG 8000, Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K | ||||||||||||||||||||
結晶 | *PLUS 溶媒含有率: 55 % | ||||||||||||||||||||
結晶化 | *PLUS | ||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: シンクロトロン / サイト: CHESS / ビームライン: A1 / 波長: 0.91 |
検出器 | タイプ: ADSC / 検出器: CCD / 日付: 1995年5月16日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.91 Å / 相対比: 1 |
反射 | 解像度: 2.04→15 Å / Num. all: 79612 / Num. obs: 79612 / % possible obs: 95.2 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 9.6 % / Biso Wilson estimate: 26.1 Å2 / Rmerge(I) obs: 0.053 / Net I/σ(I): 12.7 |
反射 シェル | 解像度: 2.04→2.11 Å / Rmerge(I) obs: 0.209 / Num. unique all: 6674 / % possible all: 81.1 |
反射 | *PLUS Num. obs: 80837 / % possible obs: 956.9 % / Num. measured all: 773440 |
反射 シェル | *PLUS % possible obs: 86.5 % |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 2.04→15 Å / Rfactor Rfree error: 0.003 / 交差検証法: THROUGHOUT / σ(F): 0 / σ(I): 0 / 立体化学のターゲット値: Engh & Huber
| ||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 35.8 Å2
| ||||||||||||||||||||||||||||||||||||
Refine analyze |
| ||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.04→15 Å
| ||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||
LS精密化 シェル | 解像度: 2.04→2.11 Å / Rfactor Rfree error: 0.012 / Total num. of bins used: 10
| ||||||||||||||||||||||||||||||||||||
Xplor file | Serial no: 1 / Param file: parhcsdx.pro / Topol file: tophcsdx.pro | ||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: X-PLOR / バージョン: 3.851 / 分類: refinement | ||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
|